182 related articles for article (PubMed ID: 11042164)
21. Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig.
Li X; Sandoval D; Freeberg L; Carter RH
J Immunol; 1997 Jun; 158(12):5649-57. PubMed ID: 9190913
[TBL] [Abstract][Full Text] [Related]
22. Defective CD19-dependent signaling in B-1a and B-1b B lymphocyte subpopulations.
Sen G; Wu HJ; Bikah G; Venkataraman C; Robertson DA; Snow EC; Bondada S
Mol Immunol; 2002 Sep; 39(1-2):57-68. PubMed ID: 12213328
[TBL] [Abstract][Full Text] [Related]
23. CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation.
Fujimoto M; Poe JC; Hasegawa M; Tedder TF
J Biol Chem; 2001 Nov; 276(48):44820-7. PubMed ID: 11584010
[TBL] [Abstract][Full Text] [Related]
24. CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes.
Yazawa N; Fujimoto M; Sato S; Miyake K; Asano N; Nagai Y; Takeuchi O; Takeda K; Okochi H; Akira S; Tedder TF; Tamaki K
Blood; 2003 Aug; 102(4):1374-80. PubMed ID: 12714520
[TBL] [Abstract][Full Text] [Related]
25. CD19 signaling pathways play a major role for murine AIDS induction and progression.
Knoetig SM; Torrey TA; Naghashfar Z; McCarty T; Morse HC
J Immunol; 2002 Nov; 169(10):5607-14. PubMed ID: 12421939
[TBL] [Abstract][Full Text] [Related]
26. A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice.
Hasegawa M; Fujimoto M; Poe JC; Steeber DA; Lowell CA; Tedder TF
J Immunol; 2001 Sep; 167(5):2469-78. PubMed ID: 11509585
[TBL] [Abstract][Full Text] [Related]
27. The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells.
Aman MJ; Lamkin TD; Okada H; Kurosaki T; Ravichandran KS
J Biol Chem; 1998 Dec; 273(51):33922-8. PubMed ID: 9852043
[TBL] [Abstract][Full Text] [Related]
28. Activation of the Rap GTPases in B lymphocytes modulates B cell antigen receptor-induced activation of Akt but has no effect on MAPK activation.
Christian SL; Lee RL; McLeod SJ; Burgess AE; Li AH; Dang-Lawson M; Lin KB; Gold MR
J Biol Chem; 2003 Oct; 278(43):41756-67. PubMed ID: 12904304
[TBL] [Abstract][Full Text] [Related]
29. CD19 regulates intrinsic B lymphocyte signal transduction and activation through a novel mechanism of processive amplification.
Fujimoto M; Poe JC; Hasegawa M; Tedder TF
Immunol Res; 2000; 22(2-3):281-98. PubMed ID: 11339363
[TBL] [Abstract][Full Text] [Related]
30. Frontline: The p85alpha isoform of phosphoinositide 3-kinase is essential for a subset of B cell receptor-initiated signaling responses.
Hess KL; Donahue AC; Ng KL; Moore TI; Oak J; Fruman DA
Eur J Immunol; 2004 Nov; 34(11):2968-76. PubMed ID: 15384044
[TBL] [Abstract][Full Text] [Related]
31. Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: activation of phosphatidylinositol 3-kinase via a CD19-independent pathway.
Bouillie S; Barel M; Frade R
J Immunol; 1999 Jan; 162(1):136-43. PubMed ID: 9886379
[TBL] [Abstract][Full Text] [Related]
32. Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.
Rip J; de Bruijn MJW; Appelman MK; Pal Singh S; Hendriks RW; Corneth OBJ
Front Immunol; 2019; 10():95. PubMed ID: 30761150
[TBL] [Abstract][Full Text] [Related]
33. Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human cell surface triggers pp60src and Akt-GSK3 activities upstream and downstream to PI 3-kinase, respectively.
Barel M; Balbo M; Le Romancer M; Frade R
Eur J Immunol; 2003 Sep; 33(9):2557-66. PubMed ID: 12938232
[TBL] [Abstract][Full Text] [Related]
34. Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors.
Weng WK; Jarvis L; LeBien TW
J Biol Chem; 1994 Dec; 269(51):32514-21. PubMed ID: 7528218
[TBL] [Abstract][Full Text] [Related]
35. The tyrosine kinases Syk and Lyn exert opposing effects on the activation of protein kinase Akt/PKB in B lymphocytes.
Li HL; Davis WW; Whiteman EL; Birnbaum MJ; Puré E
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6890-5. PubMed ID: 10359809
[TBL] [Abstract][Full Text] [Related]
36. Activation of the PKB/AKT pathway by ICAM-2.
Perez OD; Kinoshita S; Hitoshi Y; Payan DG; Kitamura T; Nolan GP; Lorens JB
Immunity; 2002 Jan; 16(1):51-65. PubMed ID: 11825565
[TBL] [Abstract][Full Text] [Related]
37. Requirement for a hsp90 chaperone-dependent MEK1/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes.
Piatelli MJ; Doughty C; Chiles TC
J Biol Chem; 2002 Apr; 277(14):12144-50. PubMed ID: 11823472
[TBL] [Abstract][Full Text] [Related]
38. Integration of activatory and inhibitory signals in human B-cells.
Sármay G; Koncz G; Gergely J
Immunol Lett; 1996 Dec; 54(2-3):93-100. PubMed ID: 9052860
[TBL] [Abstract][Full Text] [Related]
39. CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis.
Chung EY; Psathas JN; Yu D; Li Y; Weiss MJ; Thomas-Tikhonenko A
J Clin Invest; 2012 Jun; 122(6):2257-66. PubMed ID: 22546857
[TBL] [Abstract][Full Text] [Related]
40. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.
Christian SL; Sims PV; Gold MR
J Immunol; 2002 Jul; 169(2):758-69. PubMed ID: 12097378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
